AstraZeneca (AZNrealmoneynodeposit.US) rose more than 1%, hitting a record high of US$77.115. In the news, AstraZeneca announced that it would remove the COVID-19 vaccine from the world, saying the decision was based on commercial considerations. As multiple responses to variants of the COVID-19 virus,realmoneynodepositIn the development of vaccines, there has been a surplus of available booster needles, which has led to a decline in demand for the company's new coronavirus vaccine, Vaxzevria. Therefore, the company has begun to recycle vaccines globally and will also withdraw its marketing authorization in Europe. AstraZeneca insists the decision to remove the vaccine has nothing to do with court cases or the company's admission that the vaccine may cause side effects in some recipients.